// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

P wave morphology and spectral analysis of signal averaged ECG’S in paroxysmal AF patients: can this explain anatomical basis of paroxysmal AF and their propensity to recurrence

S Varanasi - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Survey to evaluate awareness and current practice of venous thromboembolism prevention following electrophysiological procedures in the United Kingdom

S E Hickman - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Effective atrial conducting size does not predict human AF vulnerability

L O'Neill - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

GP-led anticoagulation counselling for non-valvular atrial fibrillation (AF) in the community is neither comprehensive nor accurate: Results from a service improvement project.

RH Hossain - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Warfarin

Setting up a VT ablation service – where to set the bar of patient selection?

L Roche - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

‘Silent’ atrial tachyarrhythmia and potential cryptogenic stroke: a ‘real-world’ study

K Wykes - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Lower complication rates with MicraTPS versus transvenousVVI pacemakers; a single centre experience

N Ali - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Failure of timely referral to acute in-hospital heart failure services

K Musa - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Do atrial high rate episodes <6 minutes in duration in pacemaker patients increase stroke risk?

S Houghton - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

The prevalence of sleep disordered breathing in patients more than 65 years with persistent AF and the impact of AF intervention on sleep scores AT 6 month follow-up

WJT Eysenck - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Service evaluation: to identify how Plymouth NHS trust statistics for primary and secondary ICD and CRT-D intervention comply with NICE guidelines and compare with national statistics.

J T Dodd - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

The sawtooth EKG pattern of typical atrial flutter is not related to differences in conduction velocity around the flutter circuit

A Sau - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Non-invasive detection of exercise induced cardiac conduction abnormalities in sudden cardiac death survivors in the inherited arrhythmic syndromes

KMW Leong - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

A multi-centre study into the use of Ripple Mapping to differentiate atrial scar from conducting tissue during tachycardia ablation

V Luther - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

A novel mapping system for panoramic mapping of the left atrium: validation and application to detect and characterise localised sources maintaining AF

S Honarbakhsh - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

The end of pre-implant subcutaneous ICD screening? Using mathematical vector rotation to generate a personalised sensing vector resulting in universal device eligibility

BM Wiles - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characteristics of ablated rotors in terminating persistent atrial fibrillation using non-contact mapping

Xin Li - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Insights into the mechanisms of triggered activity during long qt conditions in the intact heart using optical mapping

C Alexander - Heart Rhythm Society (HRS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Balancing risks of surgery with risks of conservative management of benign adnexal masses: results from the postmenopausal follow‐up arm of IOTA5

W. Froyman - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Added value of fetal growth velocity and Dopplers to biometry in identifying small for‐gestational‐age fetuses with adverse perinatal outcome at term

A. Khalil - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved